Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
AN2 Therapeutics, Inc. market cap for the quarter ending 2026-08-06 was $230M, a 694.05% increase year-over-year.
AN2 Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $175.55M, a 507.82% increase year-over-year.
AN2 Therapeutics, Inc. market cap for the quarter ending 2026-05-07 was $166.39M, a 359.52% increase year-over-year.
AN2 Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $123.79M, a 201.98% increase year-over-year.
AN2 Therapeutics, Inc. market cap for fiscal 2026 was $230M.
AN2 Therapeutics, Inc. market cap for fiscal 2025 was $30.57M, a 25.97% decline from fiscal 2024.
AN2 Therapeutics, Inc. market cap for fiscal 2024 was $41.29M, a 93.22% decline from fiscal 2023.
AN2 Therapeutics, Inc. market cap for fiscal 2023 was $609.4M, a 229.57% increase from fiscal 2022.